Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.05
18.01.22
-
18.01.23
-2.86%
22.01.22

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€12.17
13.01.22
-
13.01.23
-7.52%
22.01.22

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.62
14.01.22
-
14.01.23
-12.67%
22.01.22

Could be worthwhile Investment >10% per year
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€24.44
14.01.22
-
14.01.23
-10.19%
22.01.22

Risky Investment
buy
Takkt AG

Start price
Target price
Perf. (%)
€15.40
09.01.22
€18.00
09.01.23
-0.52%
22.01.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€6.78
07.12.21
€10.00
07.12.22
4.13%
22.01.22

Could be worthwhile Investment >10% per year
buy
BICO Group AB

Start price
Target price
Perf. (%)
€22.96
08.01.22
€44.00
08.01.23
-7.93%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€5.42
08.01.22
€10.00
08.01.23
-11.22%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
JDC Group AG

Start price
Target price
Perf. (%)
€10.80
18.03.21
-
18.03.22
105.56%
21.01.22

Gamestop Corp.

Start price
Target price
Perf. (%)
€31.23
09.01.22
-
09.01.23
-32.39%
21.01.22

Risky Investment
overvalued
Outdated or very high risk business model
High risks in the balance sheet
buy
Heidelberger Druckmaschinen AG

Start price
Target price
Perf. (%)
€1.30
21.01.21
€3.90
21.01.22
110.71%
21.01.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
SoftBank Group

Start price
Target price
Perf. (%)
€60.20
18.06.21
-
18.06.22
-28.57%
20.01.22

Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.52
22.12.21
-
22.12.22
-12.04%
20.01.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
NorCom Information Technology GmbH & Co. KGAA

Start price
Target price
Perf. (%)
€9.30
17.06.21
€0.000
17.06.24
-7.53%
19.01.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Growths much faster than the competition
Very Future proof/growth oriented business model
buy
A.S.T. Groupe S.A.

Start price
Target price
Perf. (%)
€6.82
19.04.21
€7.50
19.04.22
-14.37%
18.01.22

Could be worthwhile Investment >10% per year
buy
IVU Traffic Technologies AG

Start price
Target price
Perf. (%)
€19.98
08.07.21
€25.00
18.01.22
-0.90%
18.01.22

buy
Holland Colours N.V.

Start price
Target price
Perf. (%)
€190.00
13.01.22
€200.00
13.01.23
0.26%
17.01.22

Could be worthwhile Investment >10% per year
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Overstock.com

Start price
Target price
Perf. (%)
€81.92
31.10.21
€90.00
31.10.22
-47.83%
15.01.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Psi AG

Start price
Target price
Perf. (%)
€27.60
14.01.21
€50.00
14.01.22
45.29%
15.01.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Fair valuation
positive Cash Flow expected
buy
CD Projekt S.A.

Start price
Target price
Perf. (%)
€54.90
13.01.21
€88.00
13.01.22
-22.35%
14.01.22

buy
Nordex SE

Start price
Target price
Perf. (%)
€14.03
15.12.21
€16.00
15.12.22
2.92%
13.01.22

Risky Investment
buy
Dr. Hoenle AG

Start price
Target price
Perf. (%)
€39.20
16.12.21
€45.00
16.12.22
0.77%
13.01.22

Good culture
Future proof or reliable business model
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€98.94
02.05.21
€123.00
02.05.22
-74.88%
13.01.22

Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Very low/no dividend yield expected